Page last updated: 2024-08-24

telmisartan and Colitis Gravis

telmisartan has been researched along with Colitis Gravis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basuony, M; Eldin, AS; Saber, S1
Araújo Júnior, RF; Araújo, AA; Fernandes, D; Guerra, GC; Lira, GA; Melo, MN; Silva, AL; Souto, KK1

Other Studies

2 other study(ies) available for telmisartan and Colitis Gravis

ArticleYear
Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity.
    Archives of biochemistry and biophysics, 2019, 08-15, Volume: 671

    Topics: Animals; bcl-2-Associated X Protein; CD36 Antigens; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Heme Oxygenase (Decyclizing); Male; NF-E2-Related Factor 2; Peroxidase; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Telmisartan; Transcription Factor RelA

2019
Telmisartan decreases inflammation by modulating TNF-α, IL-10, and RANK/RANKL in a rat model of ulcerative colitis.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:3

    Topics: Animals; Benzimidazoles; Benzoates; Colitis, Ulcerative; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Inflammation; Interleukin-10; RANK Ligand; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; Telmisartan; Tumor Necrosis Factor-alpha

2015